Sars-Cov-2 T-Cell Response in Allogeneic Hematopoietic Stem Cell Recipients Following Two Doses of BNT162b2 Vaccine

Introduction: Virus-specific humoral and cellular immune responses act synergistically to protect from viral infection. In our recent observational monocentric study of 117 hematopoietic stem cell adult recipients, we found that 54% and 83 % patients achieved a humoral response after two doses of BN...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemenceau, Beatrice, Guillaume, Thierry, Coste-Burel, Marianne, Peterlin, Pierre, Garnier, Alice, Le Bourgeois, Amandine, Imbert, Berthe-Marie, Drumel, Thomas, Mahé, Béatrice, Dubruille, Viviane, Blin, Nicolas, Lok, Anne, Touzeau, Cyrille, Gastinne, Thomas, Tessoulin, Benoit, Jullien, Maxime, Vantyghem, Sophie, Ollier, Jocelyn, Bene, Marie C, Moreau, Philippe, Le Gouill, Steven, Vie, Henri, Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
722.Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701505/
http://dx.doi.org/10.1182/blood-2021-149139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701505/
http://dx.doi.org/10.1182/blood-2021-149139

Ejemplares similares